...History November 29, 1978 Biocon’s Founding Day - the start of a biorevolution in India. Over the years, Biocon has evolved from an enzyme-manufacturing company into a fully integrated biopharmaceutical enterprise. Today, we leverage a formidable combination of proprietary fermentation technologies and research skills to develop affordable therapy for unmet medical needs Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw 1979 Biocon is the first Indian company to manufacture and export enzymes to USA and Europe 1989 Unilever plc. acquires Biocon Biochemicals Ltd. in Ireland and merges it with its subsidiary, Quest International Biocon is the first Indian biotech company to receive US funding for proprietary technologies 1990 Biocon scales up its in-house research programme, based on a proprietary solid substrate fermentation technology, from pilot to plant level 1993 Biocon's R&D and manufacturing facilities receive ISO 9001 certification from RWTUV, Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon's proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1997 Biocon spearheads initiatives in human healthcare through a...
Words: 1246 - Pages: 5
...|Biocon | Consolidated Financial Performance: | |(Rs. In Crores) | | |2005 |2006 |2007 |2008 |2009 |2010 | |Sales | |Bio Pharmaceuticals |557 |603 |728 |787 |1372 |2036 | |Enzymes |90 |85 |95 |46 |- |- | |Research and Technical Licensing Fees |66 |100 |163 |220 |237 |332 | | | |Total |713 |788 |986 |1054 |1609 |2368 | | | |Other Income |15 |5 |4 ...
Words: 2907 - Pages: 12
...Strategic Management Biocon – Term Paper Name: Naresh.N Section: B Semester : 3rd Batch : 2011-2013 PES Institute of Technology 2012 1/1/2012 INTRODUCTION Industry Biotechnology Founded 1978 Founder(s) Kiran Mazumdar-Shaw Headquarters Bangalore, India Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization.[ref 1] Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms. Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two subsidiaries— Syngene, a custom research organization, and Clinigene, a clinical research organization. Biocon’s presence straddles four main therapeutic areas—Diabetology, Cardiology, Nephrology and Oncology. History Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. November 29, 1978 Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. 1979—Becomes the first Indian company to manufacture and export enzymes to...
Words: 4681 - Pages: 19
...2012 STRATEGIC MANAGEMENT TERM PAPER ALOK KEJARIWAL 1PI11MBA13 INTRODUCTION Industry Biotechnology Founded 1978 Founder(s) Kiran Mazumdar-Shaw Headquarters Bangalore, India Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization.[ref 1] Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms. Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two subsidiaries— Syngene, a custom research organization, and Clinigene, a clinical research organization. Biocon’s presence straddles four main therapeutic areas—Diabetology, Cardiology, Nephrology and Oncology. History Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions. November 29, 1978 Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. 1979—Becomes the first Indian company to manufacture and export enzymes to USA and Europe. 1989—Unilever plc. acquires Biocon Biochemicals Ltd. in Ireland and merges it with...
Words: 4668 - Pages: 19
...CONTENTS Title Page.no 1. Introduction To Nanoparticles (2) 2. Nanoparticulate systems For Targeting (13) 3. Drug Targeting (25) 4. Approaches To Drug Targeting (29) 5. Nanoparticle Drug Delivery Market (47) 6. Future Barriers And Challenges (48) 7. Various Nanopharmaceuticals And Their Case Studies (49) 8. NanoDrug Patenting (54) 9. Conclusion (57) 10. Bibliography (58) NANOPARTICLES IN DRUG TARGETING 1. INTRODUCTION NANOPARTICLES * Nanoparticles are in solid state and are either in amorphous or crystalline They include Nanocapsules and Nanospheres.They are able to adsorb or encapsulate a drug thus protecting it against chemical and enzymatic degradation...
Words: 10751 - Pages: 44
